Center for Pharmaceutical Policy, Management, & Service Studies


The Systematic Tracking of At-Risk Medicines (STARmeds) Research Coalition Launch Event

Peningkatan Kapasitas dalam Sistem Pengawasan Obat

Selasa, 7 Februari 2023, Pukul 08.30 WIB – selesai The Groove Epicentrum, Ruang EPI 6-7 Topik: Delivering Quality-Assured Medical Products For All oleh Tim WHO Indonesia Surveilans: Sebuah Filosofi Dasar oleh Elizabeth Pisani, M.Sc., MA, PhD Farmakovigilans: Essential Tool untuk Memastikan Keamanan Obat Pembelajaran dari Studi STARmeds (Systematic Tracking of At-Risk Medicines) Andaikan Farmakovigilans [adalah] Sistem Peringatan Dini

Follow-up Study Meeting with The National Social Security Council

As a follow-up to the results of the study “Drug Governance of The National Health Insurance Program The Role of BPJS Kesehatan in Strategic Drug Spending”, the main researcher, Prof. Yusi, was invited as a resource person by BPJS Kesehatan to conduct a focus group discussion with the National Social Security Council.

Expert Meeting concerning the Role of Pharmaceutical Policy in the Social Protection Reform

Within the framework of the bilateral relations between Germany and Indonesia, GIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit), on behalf of the German Federal Ministry for Economic Cooperation and Development (BMZ), supports the Indonesian Government in implementing the Social Protection reform agenda concerning social health protection. The Head of CEPHAS, Prof Yusi Anggriani was invited to the expert meeting as a...

Diskusi Benchmarking Sistem Pengawasan Obat

Kamis, 12 Januari 2023, Pukul 13.00 WIB – selesai Online Topik: Overview Studi Penguatan Sistem Pengawasan Obat oleh CEPHAS Benchmarking Sistem Pengawasan Obat oleh Roderick L. Salenga, BScPharm, MPH, RPh (WHO Indonesia)

Lecture Series: Using Qualitative Research to tackle substandard and falsified medicines globally

On 13 September 2022, Pancasila University held a Public Lecture inviting Dr. Maarten O. Kok, as a Assistant Professor at Erasmus School of Health Policy and Management. The lecture focuses on how qualitative method is being used to face the substandard and falsified medicines. Dr. Kok explained in many settings, qualitative research was used to identify how Government see the...

Focus Group Discussion (FGD) ke-2 Studi Penguatan Sistem Pengawasan Obat: Hasil Awal Studi

Rabu, 14 Desember 2022, Pukul 12.00 WIB – Selesai HARRIS Suites FX Sudirman, Lantai 5 Topik: Analisis situasi dan potensi tantangan sistem pengawasan obat Analisis regulasi dan kelembagaan sistem pengawasan obat Usulan indikator sistem pengawasan obat periode RPJMN 2025-2029 Usulan strategi penguatan sistem pengawasan obat periode RPJMN 2025-2029

Pharmaceutical and Medical Device Policy Forum: Benefitting the e-Procurement Policy at LKPP

In a collaboration with Ministry of Health, Pharmaceutical and Medical Device Policy Forum was held in light to gather stakeholders to align the policy making process in achieving a health resiliency.

Focus Group Discussion (FGD) Ke-1 Studi Penguatan Sistem Pengawasan Obat

Selasa, 22 November 2022, Pukul 13.00 – Selesai Online Topik: Peredaran obat dan tantangan pengawasan Obat saat ini Tantangan Pengawasan Kualitas Obat Perkembangan farmakovigilans dan pengendalian resistensi antimikroba saat ini

Focus Group Discussion Peran BPJS Kesehatan dalam Belanja Kesehatan Strategis, Penanggungjawab atau Petugas Fasilitas Kesehatan (FKTP, FKRTL, Apotek PRB)

Senin/ 24 Oktober 2022, 08.30 – 13.15 WIB Online Pelaksanaan FGD terbagi dalam tiga sesi yang berbeda yaitu : FGD tingkat stakeholder/instansi pemerintahan FGD tingkat penyedia obat JKN (industri farmasi dan distributor farmasi) FGD tingkat pengguna obat JKN (FKTP, FKRTL, dan Apotek PRB)